1804 related articles for article (PubMed ID: 18808356)
1. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
[TBL] [Abstract][Full Text] [Related]
4. Central venous catheter-related infection in a prospective and observational study of 2,595 catheters.
Lorente L; Henry C; Martín MM; Jiménez A; Mora ML
Crit Care; 2005; 9(6):R631-5. PubMed ID: 16280064
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O
J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
[TBL] [Abstract][Full Text] [Related]
6. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
[TBL] [Abstract][Full Text] [Related]
7. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
Schumm K; Lam TB
Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
[TBL] [Abstract][Full Text] [Related]
8. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.
Hanna H; Benjamin R; Chatzinikolaou I; Alakech B; Richardson D; Mansfield P; Dvorak T; Munsell MF; Darouiche R; Kantarjian H; Raad I
J Clin Oncol; 2004 Aug; 22(15):3163-71. PubMed ID: 15284269
[TBL] [Abstract][Full Text] [Related]
9. Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study.
León C; Alvarez-Lerma F; Ruiz-Santana S; González V; de la Torre MV; Sierra R; León M; Rodrigo JJ
Crit Care Med; 2003 May; 31(5):1318-24. PubMed ID: 12771597
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters.
Koh DB; Gowardman JR; Rickard CM; Robertson IK; Brown A
Crit Care Med; 2008 Feb; 36(2):397-402. PubMed ID: 18216598
[TBL] [Abstract][Full Text] [Related]
11. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
[TBL] [Abstract][Full Text] [Related]
12. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
Quarello F; Forneris G; Borca M; Pozzato M
J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
[TBL] [Abstract][Full Text] [Related]
13. Jugular versus femoral short-term catheterization and risk of infection in intensive care unit patients. Causal analysis of two randomized trials.
Timsit JF; Bouadma L; Mimoz O; Parienti JJ; Garrouste-Orgeas M; Alfandari S; Plantefeve G; Bronchard R; Troche G; Gauzit R; Antona M; Canet E; Bohe J; Herrault MC; Schwebel C; Ruckly S; Souweine B; Lucet JC
Am J Respir Crit Care Med; 2013 Nov; 188(10):1232-9. PubMed ID: 24127770
[TBL] [Abstract][Full Text] [Related]
14. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial.
Yücel N; Lefering R; Maegele M; Max M; Rossaint R; Koch A; Schwarz R; Korenkov M; Beuth J; Bach A; Schierholz J; Pulverer G; Neugebauer EA
J Antimicrob Chemother; 2004 Dec; 54(6):1109-15. PubMed ID: 15537696
[TBL] [Abstract][Full Text] [Related]
15. Catheter-related bacteremia from femoral and central internal jugular venous access.
Lorente L; Jiménez A; García C; Galván R; Castedo J; Martín MM; Mora ML
Eur J Clin Microbiol Infect Dis; 2008 Sep; 27(9):867-71. PubMed ID: 18386084
[TBL] [Abstract][Full Text] [Related]
16. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
[TBL] [Abstract][Full Text] [Related]
17. Multilumen central venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study.
Templeton A; Schlegel M; Fleisch F; Rettenmund G; Schöbi B; Henz S; Eich G
Infection; 2008 Aug; 36(4):322-7. PubMed ID: 18663408
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial central venous catheters in oncology: efficacy of a rifampicin-miconazole-releasing catheter.
Schierholz JM; Nagelschmidt K; Nagelschmidt M; Lefering R; Yücel N; Beuth J
Anticancer Res; 2010 Apr; 30(4):1353-8. PubMed ID: 20530452
[TBL] [Abstract][Full Text] [Related]
19. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients.
Chelliah A; Heydon KH; Zaoutis TE; Rettig SL; Dominguez TE; Lin R; Patil S; Feudtner C; St John KH; Bell LM; Coffin SE
Pediatr Infect Dis J; 2007 Sep; 26(9):816-20. PubMed ID: 17721377
[TBL] [Abstract][Full Text] [Related]
20. Lower associated costs using rifampicin-miconazole‒impregnated catheters compared with standard catheters.
Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
Am J Infect Control; 2011 Dec; 39(10):895-7. PubMed ID: 21741122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
